New Strategies for the Development of H5N1 Subtype Influenza Vaccines: Progress and Challenges

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.5, 2011-10, pp. : 285-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]: A Review of its Use as an Active Immunization Against Influenza A Subtype H5N1 Virus

By Carter Natalie J. Plosker Greg L.

BioDrugs, Vol. 22, Iss. 5, 2008-01 ,pp. : 279-292

Adis International

Access to resources Recommend Favorite

Progress and Challenges towards the Development of Malaria Vaccines

By Tetteh Kevin K.A. Polley Spencer D.

BioDrugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 357-373

Adis International

Access to resources Recommend Favorite

A/H5N1 Prepandemic Influenza Vaccine (Vepacel®): A Guide to Its Use

By Keating Gillian M. Plosker Greg L. Lyseng-Williamson Katherine A.

BioDrugs, Vol. 26, Iss. 6, 2012-12 ,pp. : 425-430

Adis International

Access to resources Recommend Favorite

Chlamydia Vaccines: Strategies and Status

By Igietseme J.U.

BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 19-35

Adis International

Access to resources Recommend Favorite

Intranasal Administration of Influenza Vaccines: Current Status

By Eyles J.E.

BioDrugs, Vol. 13, Iss. 1, 2000-01 ,pp. : 35-59

Adis International

Access to resources Recommend Favorite